Showing results (1-10 of 172) with videos related to
Sort By:
Pageof 18
Current Opinion in Drug Discovery & Development|August 4, 2009
Regulation of pre-mRNA splicing by antisense oligonucleotidesJ K Taylor, N M DeanMethods in Molecular Medicine|February 11, 2012
Antisense oligonucleotides as research toolsJ K Taylor, S R Cooper, N M DeanNature Biotechnology|November 5, 1999
Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotidesJ K Taylor, Q Q Zhang, J R Wyatt, et al.Pharmacology & Therapeutics|August 24, 1999
Pharmacology of antisense oligonucleotide inhibitors of protein expressionS R Cooper, J K Taylor, L J Miraglia, et al.Oncogene|August 12, 1999
Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuliJ K Taylor, Q Q Zhang, B P Monia, et al.Current Opinion in Biotechnology|February 19, 2002
Functional genomics and target validation approaches using antisense oligonucleotide technologyN M DeanDrug News & Perspectives|June 14, 2003
Oligonucleotide inhibition of Fas as a potential treatment strategy in human liver diseaseH Zhang, N M DeanProceedings of the National Academy of Sciences of the United States of America|November 22, 1994
Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotidesN M Dean, R McKayTrends in Pharmacological Sciences|January 19, 2000
Sensible use of antisense: how to use oligonucleotides as research toolsK J Myers, N M DeanThe Biochemical Journal|July 15, 1990
Angiotensin II causes phosphatidylinositol turnover and increases 1,2-diacylglycerol mass but is not mitogenic in rat liver T51B cellsN M Dean, A L BoyntonPageof 18